"Enhancing lysosome biogenesis attenuates BNIP3-induced cardiomyocyte death
Introduction
In myocardial ischemia-reperfusion injury, programmed cell death causes substantial cardiac myocyte loss in addition to accidental necrosis triggered by lack of oxygen and nutrients in the ischemic core. 1 The BCL-2 family of proteins is a key regulator of the initiation and execution of programmed cell death pathways.
BNIP3
3,4 a pro-death member of this family, [5] [6] [7] is transcriptionally upregulated in hypoxic cardiac myocytes, 6, 8 and causes mitochondrial permeabilization 6, 7 and dysfunction 9 leading to cell death, which is an important determinant of cardiac dysfunction 10 and post-infarction remodeling following ischemia-reperfusion injury.
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In the setting of increased BNIP3 expression, as happens with cardiac ischemia-reperfusion injury, 6 cardiomyocyte autophagy is upregulated. 10, [12] [13] [14] Autophagy is an evolutionarily conserved lysosomal degradative pathway to remove damaged intracellular constituents that facilitates cellular homeostasis, and promotes cell survival under stress such as nutrient deprivation and hypoxia. 15 Induction of autophagy is protective in the ischemic heart, 10, [12] [13] [14] but has been implicated in causing cardiomyocyte death in myocardial reperfusion injury. 14 Forced expression of BNIP3 stimulates autophagy in cardiac myocytes, 9, 10, 13, 16 with a dosedependent increase in autophagosome abundance. 16 While BNIP3-induced autophagy has been implicated in causing cell death in cancerous cells, 17, 18 induction of autophagy in the setting of BNIP3 expression is protective in cardiac myocytes, as inhibition of autophagosome formation either pharmacologically [with 3-methyladenine (3MA) 9 ] or with co-expression of dominant negative autophagy-related (Atg) protein 5 (Atg5) 9 ,10 increases BNIP3-induced cardiomyocyte death. Conversely, enhancing autophagosome formation with forced expression of Atg5 and BECN1 appears to attenuate BNIP3-induced cell death in HL-1 cardiac myocytes. 10, 13 It is not known whether further induction of protective autophagy in BNIP3-expressing cardiac myocytes is © 2012 Landes Bioscience.
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limited by the availability of constituents of the autophagic machinery, or is actively suppressed, whereby it is unable to fully protect cells from BNIP3-induced cell death.
BNIP3 permeabilizes cardiac mitochondria, 19 promotes mitochondrial fission, 20 and/or renders them dysfunctional, 9 and the damaged mitochondria are removed via macroautophagy, 10, 20 to ensure cellular viability. Indeed, BNIP3 has been proposed as a key mediator for autophagic removal of damaged mitochondria under hypoxic stress 21, 22 and in unstressed cardiac myocytes. 23 This process involves coordinated action of multiple Atg proteins to sequester cargo, such as BNIP3-damaged mitochondria that are targeted for destruction within autophagosomes, which then fuse with lysosomes, wherein degradative enzymes break down complex organic matter in an intralysosomal acidic environment, to recycle amino acids, simple sugars and lipids. 24 Rapamycin, a potent inducer of cardiomyocyte autophagy, 14 also stimulates selective removal of dysfunctional mitochondria in yeast 25 and neurons, 26 and attenuates apoptotic cell death. 26 In this study, we evaluated whether further induction of autophagosome formation with rapamycin treatment attenuates BNIP3-induced cell death. Our results implicate lysosomal consumption as a rate-limiting factor in BNIP3-induced autophagy, whereby a strategy for enhancing flux through the macroautophagy pathway, rather than stimulating autophagosome formation alone, may accelerate removal of BNIP3-damaged mitochondria.
Recent studies have identified a critical role for transcription factor EB (TFEB), in upregulating synthesis of autophagy proteins and stimulating lysosomal biogenesis in a coordinated fashion to facilitate starvation-induced autophagy.
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We therefore evaluated whether expression of TFEB will enhance flux through macroautophagy in the setting of increased BNIP3 expression and protect against BNIP3-induced cell death. Our results demonstrate that exogenous expression of TFEB increased lysosome biogenesis, alleviating this rate limiting step in BNIP3-induced autophagy and significantly attenuated BNIP3-induced cardiomyocyte death.
Results
Rapamycin treatment does not attenuate BNIP3-induced cardiomyocyte death. BNIP3-induced autophagy appears protective in cardiac myocytes, as inhibition of autophagy increases cell death. 9, 10 In myocardial ischemia-reperfusion injury, induction of BNIP3 is a critical determinant of cell death leading to myocardial dysfunction and post-ischemic ventricular remodeling. 10, 11 Rapamycin is a potent inducer of autophagy in cardiomyocytes; 14 rapamycin pretreatment attenuates hypoxic cardiomyocyte death, 29 and mTOR inhibition with a related compound, Everolimus, reduces infarct size and attenuates postinfarction remodeling in rats subjected to cardiac ischemiareperfusion injury. 30 Accordingly, to test the hypothesis that further induction of autophagy with rapamycin will attenuate BNIP3-induced cell death, we treated neonatal rat cardiac myocytes (NRCMs) with rapamycin, both simultaneously and 24 h after adenoviral transduction of BNIP3 and assessed cell death at 48 h. BNIP3 expression induced autophagy with a significant increase in punctate GFP-LC3 localization ( Fig. 1A and B) and increased autophagosome-bound LC3-II abundance (Fig. 1C) , without a change in LC3 transcription (Fig. S1A) . Importantly, levels of p62, a protein that brings ubiquitinated aggregates into autophagosomes and gets consumed during autophagy, 31 were elevated in BNIP3-expressing cells (Fig. 1C) , with a trend toward reduction in p62 transcription (Fig. S1B) , suggesting BNIP3-induced impaired clearance of p62. Rapamycin added simultaneously (Fig. 1A) stimulated autophagy with increased autophagosome abundance (Fig. 1A and B) , and increased LC3-II expression with a decline in p62 abundance (Fig. 1C) as compared with control. Interestingly, while rapamycin increased autophagosome numbers (Fig. 1A and B ) and LC3-II abundance (Fig. 1C) in BNIP3-expressing cells, p62 levels did not decline (Fig. 1C) indicating lack of p62 clearance despite further induction of autophagosome formation by rapamycin. BNIP3 expression provoked a~3.6-fold increase in cell death as compared with controls ( Fig. 1D and E) , and further induction of autophagy with rapamycin treatment either simultaneously or 24 h after induction of BNIP3 expression (Fig. 1C) , did not affect BNIP3-induced cell death ( Fig. 1D and E) . Inhibition of autophagosome formation with 3MA increased cell death in both control and BNIP3-expressing cells, confirming a beneficial role for autophagy in cardiomyocyte homeostasis and protection from BNIP3-induced cell death, as previously described.
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BNIP3 induces autophagosome accumulation in cardiac myocytes. Accumulation of p62 with increased autophagosome abundance in BNIP3-expressing cells (Fig. 1C) suggested impairment of autophagosome processing. Accordingly, we examined autophagosome abundance in the absence and presence of chloroquine (CQ), a lysosomal acidification inhibitor, which leads to accumulation of autophagosomes due to impairment in autophagosome-lysosome fusion and autophagosome removal. 32 Cumulative flux, expressed as a ratio of autophagosome abundance in the presence of CQ to autophagosome numbers in its absence, was partially impaired with BNIP3 expresssion as compared with LacZ-expressing adenovirus-transduced control cells (1.3 vs. 4.4 in the control; Fig. 2A and B) . In contrast, nutrient deprivation and rapamycin led to autophagy induction with better preserved flux as compared with BNIP3-expressing cells (ratio of autophagosome abundance with/without CQ: 2.5 with nutrient deprivation and 2.5 with rapamycin; Fig. 2B ). We next examined the relative abundance of autophagosomes and autolysosomes in BNIP3-expressing NRCMs lentivirally transduced with an mCherry-GFP dual tandem tagged LC3. While autophagosomes are evident as dual fluorescent LC3 puncta (red + green = yellow), autolysosomes appear red, as GFP fluorescence is quenched in the acidic intralysosomal environment. 33 Control cells demonstrated basal autophagy with a preponderance of autolysosomes ( Fig. 2C and D) . BNIP3 expression led to increased autophagosome abundance, without an increase in autolysosomes ( Fig. 2C and D) . This is in contrast to the predominant increase in autolysosomes as compared with controls, observed with autophagy induction due to nutrient deprivation and rapamycin treatment, indicating intact flux through the macroautophagy pathway under these conditions ( Fig. 2C and D) . Chloroquine treatment of cells transduced with control (LacZ) adenovirus increased autophagosome-bound LC3-II abundance and led to p62 accumulation (Fig. 2E) , which was associated with a 1.8-fold increase in cell death (Fig. 2F) , likely secondary to autophagosome accumulation ( Fig. 2A and B) and lack of homeostatic clearance of autophagic cargo such as damaged mitochondria. In contrast, while CQ treatment of BNIP3-expressing cells caused a further increase in LC3-II abundance (as compared with BNIP3-expressing cells treated with diluent; Fig. 2E) ; there was no further p62 accumulation (Fig. 2E) , suggesting impaired autophagosome clearance in BNIP3-expressing cells. In contrast to the effect of CQ on cell death in control cells, the effect of chloroquine treatment on cell death in BNIP3-expressing cells was marginal (1.2 fold; Fig. 2F ), correlating with an underlying impairment in clearance of autophagosomes and possibly damaged mitochondria in BNIP3-expressing cells in the absence of CQ treatment. Interestingly, CQ treatment provoked an accumulation of the monomeric, but not the dimeric forms of BNIP3 (Fig. 2E) and rapamycin treatment preferentially reduced monomeric BNIP3 protein levels (Fig. 1C) , indicating an underlying impairment in clearance of BNIP3-dimer and likely mitochondria that are permeabilized only by the dimeric forms of BNIP3, during BNIP3-induced autophagy. 4, 5, 34, 35 The transmembrane domain is essential for the interaction of BNIP3 with LC3. The C-terminal transmembrane domain of BNIP3 is essential for targeting mitochondria 4, 5 and the endoplasmic reticulum, 36 inducing mitochondrial permeabilization and causing cell death. [4] [5] [6] [7] 34 Recent studies have identified an interaction between BNIP3 and LC3, 9 likely via amino acid sequences upstream of BNIP3's C-terminal transmembrane domain, based on similarities with a related protein NIX/ BNIP3L, 37, 38 suggesting that BNIP3 acts as a 'receptor' for targeting mitochondria to autophagosomes. 9, 10, 23 Interestingly, an endogenous hypoxia-inducible splice variant of BNIP3 lacking the transmembrane domain (BNIP3Dex3), but retaining the higher affinity LC3 interaction region (LIR; homologous to LIR labeled W35 in BNIP3L 37 ) was recently identified. 39 It is conceivable that at high levels of BNIP3 expression, such as may occur during hypoxia, 6, 8 the interaction between concomitantly hypoxia-upregulated BNIP3Dex3 39 and LC3 protein involving the non-transmembrane segment of the BNIP3 protein, such as observed in silico with BNIP3L/NIX, 37, 38 leads to sequestration of the available LC3, preventing its role in autophagic removal of damaged mitochondria. To examine this premise, we assessed the interaction of a transmembrane deletion mutant of BNIP3 (BNIP3DTM; with all putative LIR regions 37 intact) and LC3, each tagged with a FRET compatible fluorophore partner in HEK 293 cells. As previously demonstrated, 4 BNIP3DTM demonstrated diffuse cellular localization ( Fig. 3A; Fig. S2 ), and did not induce autophagy, 10 assessed as increased punctate LC3 localization, as compared with controls ( Fig. 3A; Fig. S2 ). Interestingly, induction of autophagy by rapamycin treatment led to markedly increased punctate LC3 localization, but did not alter the subcellular localization of BNIP3DTM (Fig. S2) , suggesting that the interaction between BNIP3 and LC3 requires activation of autophagy with an intact transmembrane domain. Indeed, assessment of interaction between full-length BNIP3, and BNIP3DTM with LC3 by FRET (Fig. 3A and B ) and co-immunoprecipitation as previously described for BNIP3 and LC3 9 ( Fig. 3C) , confirmed an obligate role for the transmembrane domain in the interaction between BNIP3 and LC3, potentially involving additional proteins recruited upon BNIP3-induced mitochondrial permeabilization and dysfunction 9, 16, 19, 23 as observed with a closely related protein, BNIP3L/ NIX. 37, 41 Also, while full-length BNIP3 colocalized both with LC3 and mitochondria in NRCMs, BNIP3DTM did not (Fig. S3) ; indicating that only the full-length BNIP3 protein acts as a receptor to target damaged mitochondria into autophagosomes, as observed with the closely related protein, BNIP3L/ NIX. 37, 41 This suggests that increased BNIP3 expression results in accumulation of autophagosomes containing full-length BNIP3-targeted mitochondria, 7,9,10,13,16 with potential deleterious consequences secondary to impaired removal of these damaged organelles. (C) 3T3 fibroblasts were co-transduced with adenoviruses coding for FLAG-BNIP3, or HA-BNIP3DTM and GFP-LC3 (100 MOI each for 48 h) and extracts subjected to co-immunoprecipitation employing BNIP3, GFP and IgG control antibodies.
BNIP3 does not target lysosomes or alter lysosome pH. Accumulation of autophagosomes in the setting of increased BNIP3 expression may occur due to inhibition of subsequent autophagosome processing. Additionally, previous studies have suggested direct targeting of BCL-2 family proteins to lysosomes as a potential mechanism for activation of cell death. 42, 43 Accordingly, we examined whether BNIP3 targets to lysosomes or alters lysosomal integrity. BNIP3 colocalizes together with both lysosomes and mitochondria in NRCMs (Fig. 4A, see arrows,  bottom panel) . This may indicate that BNIP3 targets to the lysosomes independently or via localization on mitochondria engulfed within autophagosomes that have subsequently fused with lysosomes. Accordingly, to examine the organelle-specific localization of BNIP3, we performed subcellular fractionation to isolate fractions enriched in lysosomes, mitochondria and the endoplasmic/sarcoplasmic reticulum in HL-1 cardiac myocytes, a cell line that displays mammalian cardiomyocyte physiology and can be easily expanded as necessary. 44 As previously demonstrated, 36 BNIP3 protein segregated to subfractions enriched in the mitochondrial marker COX IV, and the endoplasmic reticulum marker CALNEXIN, but not a lysosome marker, LAMP-1 (Fig. 4B) .Taken together, these data indicate that BNIP3 protein does not target lysosomes independently of being localized to mitochondria, and suggest that autophagosome-lysosome fusion in the setting of BNIP3-induced autophagy is not disrupted. Additionally, BNIP3 did not cause lysosome permeabilization (Fig. S4) or alter lysosome pH in NRCMs (Fig. 4C) .
BNIP3-induced autophagososme formation leads to lysosome consumption. We next examined whether BNIP3 affects lysosome abundance. Expression of full-length BNIP3, but not BNIP3DTM, provoked a~20% reduction in lysosome numbers in NRCMs as assessed by uptake of two pH-dependent lysosome probes, LysoTracker red (Fig. 5A-C) and LysoTracker green (Fig. S5A) , and cellular levels of LAMP-1 ( Fig. 5D and H;  Fig. S6A ), an abundant lysosomal membrane protein. This decline in lysosome numbers closely tracked LC3-II and p62 accumulation, and was observed early (within 24 h of BNIP3 transduction; Fig. S5B and S5C ), and at 10-fold lower infective viral dose (MOI = 10; Fig S5D and S5E) . BNIP3-induced decline in lysosome abundance was prevented by 3MA-mediated inhibition of BNIP3-induced autophagy (Fig. 5C) , suggesting lysosomal consumption during macroautophagy as the mechanism for reduced lysosome abundance in BNIP3-expressing cells, without requisite replenishment as observed in starvation-and rapamycin-induced autophagy. 28, 45 Interestingly, a decline in LAMP-1 levels was also observed in NRCMs subjected to prolonged hypoxia, which provokes maximal accumulation of the BNIP3 protein 8, 46 ( Fig. S7) , suggesting that BNIP3-induced lysosomal consumption may be of pathophysiological significance in ischemic cardiac injury.
Enhancing lysosomal biogenesis with transcription factor EB expression rescues BNIP3-induced cell death. To determine whether restoring lysosome abundance would promote autophagosome clearance in BNIP3-expressing NRCMs, we expressed the transcription factor EB (TFEB), which was recently described to promote biogenesis of lysosomes 27,28 and autophagy proteins. 28 Adenovirally transduced TFEB localized to the nucleus (Fig. 5A) and expression of TFEB increased lysosome abundance ( Fig. 5A-C ; Fig. S5A ) with increased abundance of LC3 ( Fig. 5D and F ; Fig. S6A ) and LAMP-1 ( Fig. 5D and H; Fig. S6A ), induced autophagosome formation as evidenced by punctate GFP-LC3 localization (Fig. S8) and increased the ratio of LC3-II/asarcomeric actin ( Fig. 5D and E) , as previously described. 28 Importantly, TFEB expression restored lysosome abundance in BNIP3-expressing cells ( Fig. 5A-C; Figs. S5A and S6A), with a reduction in the ratio of LC3-II to LC3-I ( Fig. 5D; Fig. S6B ) and reduced p62 accumulation ( Fig. 5D and G; Fig. S6A ) as compared with NRCMs treated with BNIP3 alone. Interestingly, while lower expression of TFEB (MOI = 10) did not alter BNIP3 protein abundance (Fig. S6A) , higher expression of TFEB (MOI = 100) was associated with a decline in BNIP3 protein levels ( Fig. 5D; Fig. S9 ) which was prevented by inhibition of autophagy with 3MA (Fig. S9) , suggesting enhanced clearance of BNIP3 by TFEB-induced autophagy. Indeed, exogenous expression of TFEB restored autophagosome processing in BNIP3-expressing cells, with a decline in prevalence of autophagosomes and a commensurate increase in autolysosomes ( Fig. 6A and B) as compared with cells expressing BNIP3 alone. As shown previously, 9,10 BNIP3DTM did not stimulate cardiomyocyte autophagy ( Fig. 5D and E) or increase death (Fig. 6C) . Enhancement of autophagosome clearance by TFEB was associated with a dose-dependent attenuation in BNIP3-induced cell death (Fig. 6C) and in BNIP3-induced TUNEL positivity ( Fig. 6D  and E) . This was likely secondary to enhanced removal of damaged mitochondria by a global induction of the autophagic machinery driven by TFEB in the setting of BNIP3 expression, as BNIP3 provoked an increase in green fluorescent JC-1 monomers (Fig. 7A and B, top) with a reduction in red fluorescent JC-1 J-aggregates ( Fig. 7A and B, bottom) and markedly increased green to red fluorescence ratio (vs controls, Fig. 7C ), indicating increased depolarized mitochondria and reduced numbers of normally polarized mitochondria, 47 and suggesting accumulation of damaged mitochondria 48 ( Fig. 7A-C) , which was reversed by co-expression of TFEB (Fig. 7A-C) .
Discussion
In this study, we demonstrated that BNIP3-induced autophagy in cardiac myocytes was rate limited by lysosome consumption, which led to upstream autophagosome accumulation. Expression of transcription factor EB (TFEB) stimulated lysosome biogenesis and restored processing of autophagosomes. The resultant enhanced flux through the macroautophagy pathway attenuated BNIP3-induced cell death.
The primary stimulus for autophagy induction with increased BNIP3 expression, as occurs with hypoxic insult, 6, 8 appears to be BNIP3 targeting to the organelle, in particular the mitochondria. 4 ,9,10,36 Indeed, our data confirm an obligate role for the transmembrane domain of BNIP3 protein, which is essential for organelle targeting, 4, 36 in inducing autophagy. BNIP3 induces mitochondrial damage by multiple mechanisms, such as mitochondrial outer membrane permeabilization in concert with Bax and Bak, 49 mitochondrial permeability transition by a novel cyclophilin D-independent mechanism, 19 mitochondrial fragmentation in concert with Opa 19,50 and Drp1, 20 and mitochondrial energetic dysfunction via protease-mediated cleavage of oxidative phosphorylation/electron transport chain proteins. 9, 23 The obligate role of the transmembrane doman in the interaction of BNIP3 with LC3 proteins (see Fig. 3 ) suggests that mitochondriallylocalized BNIP3 interacts with autophagosome-bound LC3-II as a 
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receptor to facilitate autophagic removal of these damaged mitochondria. 9, 10, 23 Recent studies have employed bafilomycin A 1 to inhibit lysosome acidification and assess cumulative flux through the macroautophagy pathway in BNIP3-expressing cells, and suggest that autophagic flux is intact in this setting. 9 While a BNIP3-induced increase in autophagosomes is incontrovertible, the ratio of autophagosome abundance with bafilomycin A 1 treatment as compared with no treatment was low in BNIP3-expressing cells when compared with a similar ratio in controls (1.6 in BNIP3-expressing cells vs. 5 in controls). 9 These data are comparable to our results with CQ (which also inhibits lysosomal acidification; see Fig. 2A and B) , and taken together, suggest a partial impairment in autophagosome processing in BNIP3-expressing cells. Our data also suggest that under conditions of high levels of BNIP3 expression as may occur with myocardial ischemiareperfusion injury, 6, 8 autophagosome processing is impaired, as indicated by accumulation of p62, a protein that gets consumed in the autophagic process, 31 and accumulation of autophagosomes without a commensurate increase in autolysosomes. Impaired autophagosome clearance prevents removal of BNIP3-damaged mitochondria, similar to that observed with preventing autophagosome formation (e.g., with 3MA, or dominant negative Previous studies have demonstrated that inducing autophagosome formation with transfection of Atg5 10 or Becn1 13 attenuates BNIP3-induced cell death. We observed that stimulating autophagosome formation with rapamycin does not attenuate BNIP3-induced cell death (Fig. 1) . The observed differences may be attributable to level of BNIP3 expression, whereby autophagosome accumulation is only observed at high levels (as obtained with adenoviral transduction of Bnip3), but not at lower levels typically achieved with transfection based-methods in cardiac myocytes. Alternatively, the previous studies 10, 13 may indicate a specific impairment in ATG5 and/or BECN1 levels or function in the context of BNIP3-induced autophagy, whereby restoring www.landesbioscience.com Autophagyeither one attenuates BNIP3-induced cell death. Exogenous administration of TFEB is not known to stimulate synthesis of ATG5 and BECN1, 27,28 but could potentially have overcome this limitation via synthesis of alternative proteins in the autophagic pathway, resulting in the observed benefits. Also, while our data suggest that autophagosome-lysosome fusion is not completely disrupted in BNIP3-expressing cells, it may be impaired, and the observed beneficial effects of TFEB expression may relate at least in part to normalization or acceleration of this process. These hypotheses require further investigation.
We found that BNIP3 expression triggers a decline in lysosome abundance in cardiac myocytes. This appears to be due to lysosome consumption in the autophagy process, as it was prevented by inhibition of autophagosome formation with 3MA, and did not occur with the transmembrane deletion variant BNIP3DTM which does not induce autophagy. Importantly, BNIP3 did not target to or permeabilize lysosomes whereby it could provoke a lysosomal pathway for cell death. 51 Indeed, enhancing lysosomal biogenesis in that setting would have increased BNIP3-induced cell death, akin to adding fuel to the fire. The decline in lysosome numbers with BNIP3-induced autophagy indicates a lack of recruitment of, or an active suppression of mechanisms to enhance lysosomal biogenesis endogenously as occurs in starvation-induced autophagy. 28 Notably, rapamycin treatment, which results in an initial depletion of lysosomes followed by a rapid restoration of lysosome abundance, 45 did not attenuate BNIP3-induced cell death, suggesting that the observed beneficial effects of TFEB relate to its ability to coordinately upregulate the entire autophagic machinery. 28 It is interesting to speculate that active suppression of autophagy by limiting the process at various steps is a mechanism inherent to the programmed cell death process, which prevents the prosurvival function of lysosome-mediated autophagy, and requires further study.
Materials and Methods
Cardiac myocyte culture. Neonatal rat cardiac myocyte (NRCM) cultures were prepared as described.
14 Briefly, hearts were removed from 1-d-old Sprague-Dawley rats, the atria and great vessels were trimmed off, and tissue was finely minced followed by sequential digestion with 0.5 mg/ml collagenase (WAKO, LK03303). Ventricular cardiomyocytes were separated from fibroblasts by differential plating and were cultured in gelatin-coated 12-well tissue culture plates (0.4 hearts/well) in media containing Dulbecco's modified Eagle's medium, 10% horse serum, 5% fetal calf serum, 100 mmol/L bromodeoxyuridine, penicillin, streptomycin and L-glutamine. Nutrient deprivation was induced as previously described.
14 HL-1 cardiac myocytes were a kind gift from Dr. William Claycomb, Louisiana State University, New Orleans, and were cultured as described.
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Generation of viral constructs. The coding sequence for rat Map1lc3β (microtubule-associated protein 1 light chain 3β) was cloned in frame with GFP in pAcGFP-C vector (Clontech, 632470). The GFP-LC3 coding sequence was then cloned downstream of mCherry in pLVx-mCherry-C vector (Clontech, 632561) and lentiviral particles coding for expression of dual fluorescent tandem tagged mCherry-GFP-LC3 were generated per the manufacturer's instructions at the Hope Center Viral Vectors Core at Washington University School of Medicine. Transduction of lentiviruses was facilitated with polybrene, at 8 mg/ml (Sigma, H9268). Coding sequences for human BNIP3, BNIP3DTM (see Supplementary methods for details) and human TFEB, with N-terminal FLAG (DYKDDDDK; on BNIP3) and HA (YPYDVPDYA; on BNIP3DTM and TFEB) tags were cloned into pENTR-TOPO vector (Invitrogen, 45.0218) and recombinant adenoviral constructs generated with Clonase mediated recombination (Virapower, Invitrogen, K493000). Adenoviruses were generated in HEK293A cells and titered per the manufacturer's instructions.
Assessment of cell death. Cell death assays were performed in 96-well plates and chamber slide (Nunc, Fisher, 177429) format with the Live-Dead Cytotoxicity Viability kit for Mammalian cells (Invitrogen, L3224) per manufacturer's instructions as described. 52 Quantitative assessment of fluorescence was performed with BioTek Synergy-2 microplate reader equipped with the appropriate filter sets (Green: Excitation 485 ± 10 nm, Emission 528 ± 10 nm; Red: Excitation 540 ± 7.5 nm, Emission 620 ± 20 nm) at Chemical Genetics Screening Core at Washington University School of Medicine. TUNEL staining was performed as described.
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Immunofluorescence imaging. Imaging for GFP-LC3 and mCherry-GFP-LC3 localization, and immunofluorescence for FLAG and HA epitopes (with Alexa Fluor 488 and 594 tagged secondary antibodies from Invitrogen, A21202 and A21207) were performed on 4% paraformaldehyde fixed cells using Axioscap upright microscope; AxioCam HRC camera and Plan Neofluar objective (63X, NA1.25, oil) (Zeiss) fitted with appropriate filter cubes. Images were acquired and analyzed using Zeiss Axiovision software. Confocal imaging was performed on a Zeiss LSM 510 NLO Meta using an Achroplan 63X (NA 0.95) water objective and Zeiss LSM software. Punctate fluorescent tagged LC3 dots were counted and expressed as number per nucleus using Image J software (NIH) as described. 53 Organelle imaging was performed using LysoTracker red (L7528) and green (L7526), MitoTracker deep red FM (M22426), Hoechst dye (H3570), JC-1 (T3168; all from Invitrogen) and DAPI (Vector Labs; H-1200) per manufacturer's protocols. Acridine orange (Biotium, 40039) staining was performed as described. 54 Assessment of lysosomal pH was performed with pH-sensitive dye-Lysosensor yellow/ blue DND-160 (Invitrogen, L7545) following manufacturer's instructions.
Subcellular fractionation. HL-1 cells (7 ¾ 10 7 cells per group) were adenovirally transduced with LacZ (control) and Bnip3 [at MOI (multiplicity of infection) = 100] for 48 h and subjected to subcellular fractionation on a discontinuous nycodenz gradient using procedures modified from protocols previously described. 55, 56 Briefly, cells were homogenized in a medium containing 0.25 M sucrose, 1 mM Na 2 EDTA, 10 mM HEPES adjusted to pH 7.4 with NaOH. Homogenates were cleared off unbroken cells with a brief 120 g spin and a mitochondria +lysosome rich fraction was sedimented at 20,000 g for 20 min. This fraction was layered on a discontinuous nycodenz (Optiprep, Sigma, D1556) gradient (19%, 27% and 30%) and subjected to ultracentrifugation at 110,000 g for 2 h in a swinging bucket rotor. Three-milliliter fractions were collected from the gradient; and lysosomes, and mitochondria with mitochondria-associatedmembranes were recovered from the top and 3rd (from top) fractions, respectively. The supernatant from the 20,000 g spin was subjected to ultracentrifugation at 100,000 g for 1 h to recover endoplasmic reticulum rich fraction; with resultant supernatant concentrated as cytosol using Ultracel-10K protein filters (Millipore, UFC801024).
Assessment of FRET interaction. Constructs coding for DsRed-BNIP3 or DsRed-BNIP3DTM (see supplementary methods for details) were co-transfected with GFP-LC3 in HEK293 cells. Construct encoding for DsRed-monomer-GFP fusion protein 40 was employed as positive control. Normalized FRET was assessed by confocal microscopy and BioTek Synergy-2 microplate reader equipped with the appropriate filter sets as described. 40 Flow cytometry. NRCMs were incubated with LysoTracker Red (1 mmol/L for 15 min at 37°in 5% CO 2 ) or JC-1 (10 mg/ml for 10 min at 37°C in 5% CO 2 ) and subjected to flow cytometry on FACScan instrument (Becton-Dickinson) as described. 57 Cyflogic software (CyFlo) was employed to analyze 20,000 events per run.
Co-immunoprecipitation studies. NIH 3T3 fibroblasts were transduced with adenoviruses to co-express BNIP3 or BNIP3DTM and GFP-LC3 (all at 100 MOI); and crude extracts prepared as described. One and a half mg of total protein was incubated with anti-GFP (Abcam, ab0290) and normal rabbit IgG; and immunoprecipitation performed using Dynabeads 1 protein G (Invitrogen, 100.07D).
Immunoblotting. Immunoblotting was performed on cardiac and cellular extracts using previously described techniques.
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Antibodies employed were as follows: FLAG (Sigma, F3165); HA (Sigma, H6908), Bnip3 (Abcam, Ab10433), GFP (Clontech, 632375), LAMP1 (Abcam, AB24170); LC3 (Novus Biologicals, NB100-2220); p62 (Abcam, ab5416); and a-sarcomeric actin (Abcam, ab52219). Image J software was employed for quantitative analysis. Protein abundance was normalized to a-sarcomeric action expression and reported as fold change vs. control. Chemicals employed were obtained as follows: rapamycin (EMD4Biosciences, 553212); chloroquine (Sigma, CC6628); 3-methyladenine (EMD4Biosciences, 189490); and staurosporine (Sigma, S6942).
Statistical analysis. Results are expressed as mean ± SEM. Statistical differences were assessed with the unpaired 2-tailed Student's t-test for two experimental groups and one-way ANOVA for multiple groups with SPSS software. Bonferroni's post-hoc testing was employed after ANOVA for testing for significant differences between groups. A two-tailed p value of less than 0.05 was considered statistically significant.
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